50 likes | 59 Views
The global atrial fibrillation devices market is estimated to be valued at US$ 3.9 Bn in 2020, with the market expected to exhibit a healthy CAGR of more than 14% during the forecast period (2020-2030).
E N D
Atrial Fibrillation Devices Market Report Id : PMRREP31531 Category : Life Science & Healthcare ©2020 Persistence Market Research, All Rights Reserved
About Persistence Market Research Customized Research Persistence Market Research(Persistence Market Research) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. Persistence Market Research is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Syndicated Research Investment Research Social Media Research Research Capabilities Sector Coverage • Automotive and Transportation • Electronics, Semiconductor, and ICT • Retail and Consumer Products • Industrial Automation and Equipment • Customized Research • Syndicated Research • Investment Research • Social Media Research • Chemicals & Materials • Food and Beverages • Services and Utilities • Energy, Mining, Oil, and Gas Subscription Information For detailed subscription information please contact Website: www.persistencemarketresearch.com For sales queries or new topics email us on: sales@persistencemarketresearch.com
The Atrial Fibrillation Devices Market To Grow On A Remarkable Note With Top Key-Players Interventional electrophysiology devices have already had a significant impact on patients suffering from cardiac arrhythmias, and are being increasingly adopted as a permanent treatment option for atrial fibrillation. Procedures such as radiofrequency ablation, cryoablation, and cox-maze are well performed in today’s practice. Recent studies have found cryoablation to be more effective than medical management, and it is widely used in medical surgical practice. The overall market is primarily driven by the growing prevalence of atrial fibrillation amongst the geriatric as well as adult population, and the adoption of minimally-invasive techniques for the permanent treatment of atrial fibrillation. Moreover, the use of innovative techniques, advancements in technology, and favorable reimbursement scenario are some other factors responsible for propelling the growth of the atrial fibrillation devices market. As such, the global atrial fibrillation devices market is estimated to be valued at US$ 3.9 Bn in 2020, with the market expected to exhibit a healthy CAGR of more than 14% during the forecast period (2020-2030). Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/31531
Want more insights? PMR brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global atrial fibrillation devices market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the atrial fibrillation devices market on basis of product (diagnostics – conventional EP catheters, mapping catheters, CS catheters, and ICE catheters) and therapeutics – EP ablation, maze surgery, and LAA management devices), technology (radiofrequency, crythotherapy, ultrasound, and others), and end user (hospitals, ambulatory surgical centers, and cardiac catheterization laboratories), across seven major regions. Access Full Report @ https://www.persistencemarketresearch.com/checkout/31531